CVS Health Corporation (CVS)
CVS Considering Breakup Amid Strategic Review
CVS is conducting a strategic review of options including a possible breakup, as the company faces headwinds from its drugstore chain and Aetna health insurance arm, according to a person familiar with the matter. Dasha Afanasieva reports on Bloomberg Television.
CVS reportedly ready to the 'splits'
CVS Health Corp (NYSE:CVS) is exploring options to split its retail and insurance divisions in response to investor pressure, according to a Reuters exclusive. The potential separation, which may lead to two publicly traded entities, would reverse CVS's $70 billion acquisition of Aetna.
CVS is working with advisors on strategic review, sources say
CVS Health's board has engaged advisors to conduct a strategic review of its business, according to people familiar with the matter. The review has been ongoing for some time, said the people, but there is no certainty on what actions, if any, the company will take.
CVS is reportedly reviewing its options — including a possible breakup
Drugstore chain CVS Health Corp. in recent weeks has been reviewing its options as a company — among them a potential breakup — the Wall Street Journal reported on Monday.
Exclusive: CVS explores options including potential break-up, sources say
CVS Health is exploring options that could include a break-up of the company to separate its retail and insurance units, as the struggling healthcare services company looks to turn around its fortunes amid pressure from investors, people familiar with the matter told Reuters.
CVS Health: Glenview's Activism Ramps Up Pressure On Management
CVS has faced consecutive guidance downgrades and a significant share price drop due to underperformance in its Medicare Advantage segment and rising costs. CEO Lynch's leadership is under scrutiny, with hedge fund Glenview Capital pushing for strategic changes, potentially including management overhaul, and requesting meetings with senior management. Despite current struggles, CVS's long-term potential remains, hinging on improving Medicare Advantage margins and avoiding further downgrades.
Stock Of The Day: Is It Time To Sell CVS?
“Sell at former peaks” is an old Wall Street expression. People say this because stocks tend to run into resistance when they rally to a price level that has been a peak.
CVS Cuts 2900 Jobs Amid Hedge Fund Pressure
CVS Health is reportedly meeting with a top investor on ways to enhance its business. The pharmacy/healthcare chain was set to meet Monday (Sept.
CVS Health Stock Gains on Report of Planned Meeting With Glenview Capital
CVS Health (CVS) shares rose Monday on a report that major investor hedge fund Glenview Capital Management was planning to hold a meeting today with executives of the pharmacy and health care firm about making changes to its operations.
Hedge fund mogul Larry Robbins seeks overhaul at struggling CVS: report
Hedge fund mogul Larry Robbins will meet with executives at struggling drugstore chain CVS on Monday to present a turnaround plan that the Glenview Capital founder hopes will improve the firm's operations, according to a report.
CVS's stock rises nearly 3% on report of meeting with large hedge fund Glenview Capital
Gathering signals potential changes to improve shareholder value after the company's weak stock performance.
CVS Stock Is Rising. An Activist Wants Changes.
Glenview Capital Management will meet with top CVS executives to exchange ideas on how to make improvements at the healthcare company, according to a report from The Wall Street Journal.
